And what reason would that be. All I can see is a sell off to 1.5c. Next read out is now in doubt.
Strong Scientific approach, choose cognition over depression in a depression trial.
They have strong evidence that 10mg is the way to go, but all they give us is PET scan. And don't start me on AD biomarkers. Irrelevant here.
- Forums
- ASX - By Stock
- ACW
- Ann: ACW XanaCIDD phase 2a trial topline results
Ann: ACW XanaCIDD phase 2a trial topline results, page-90
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACW (ASX) to my watchlist
|
|||||
Last
2.8¢ |
Change
-0.003(9.68%) |
Mkt cap ! $78.63M |
Open | High | Low | Value | Volume |
3.0¢ | 3.1¢ | 2.7¢ | $564.6K | 19.74M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 2004520 | 2.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.8¢ | 29247 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 3384849 | 0.027 |
14 | 2304588 | 0.026 |
23 | 4527643 | 0.025 |
9 | 2644096 | 0.024 |
6 | 870000 | 0.023 |
Price($) | Vol. | No. |
---|---|---|
0.028 | 1027107 | 8 |
0.029 | 1441665 | 7 |
0.030 | 2910884 | 13 |
0.031 | 2351835 | 8 |
0.032 | 1442122 | 8 |
Last trade - 12.53pm 13/08/2024 (20 minute delay) ? |
Featured News
ACW (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online